View current press releases, to submit a press release please contact [email protected] for pricing.
ISELIN, N.J., Nov. 23, 2023 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK) (“Outlook Therapeutics”), a late clinical-stage biopharmaceutical company working to develop and launch the first FDA-approved ophthalmic formulation of bevacizumab-vikg for use in retinal indications, announced today that, due to demand, the…
VANCOUVER, British Columbia, Nov. 23, 2023 (GLOBE NEWSWIRE) — Madison Pacific Properties Inc. (the Company) (TSX: MPC and MPC.C), a Vancouver-based real estate company announces the results of operations for the year ended August 31, 2023. The results reported are…
Los ingresos del tercer trimestre se mantuvieron estables en 305.300 millones de KRW Los beneficios de explotación disminuyeron ligeramente debido a la fuerte inversión en I+D. Se prevé la introducción de nuevas pruebas de diagnóstico capaces de detectar 22 objetivos,…
TORONTO, Nov. 23, 2023 (GLOBE NEWSWIRE) — Revival Gold Inc. (TSXV: RVG, OTCQX: RVLGF) (“Revival Gold” or the “Company”), a growth-focused gold exploration and development company, announces voting results for the election of directors at its Annual General Meeting (“AGM”)…
TORONTO, Nov. 23, 2023 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Company”) (TSX Venture: PTK; OTCQX: POETF), the designer and developer of the POET Optical Interposer™ and Photonic Integrated Circuits (PICs) for the data center and tele-communication markets,…
ANAHEIM, Calif., Nov. 23, 2023 /PRNewswire/ — On November 9th, 2023 at the Disneyland Hotel, the Alliance for Quality Construction (AQC) awarded this year’s Q Award to the Disneyland Resort for its $1 Billion construction of the new STAR WARS: Galaxy’s…
IRONWOOD, Mich., Nov. 23, 2023 (GLOBE NEWSWIRE) — Keweenaw Land Association, Limited (OTC US: KEWL) today announced it has entered into a definitive agreement to sell its timber assets to an entity managed by a non-affiliated large institutional timberland investment…
VANCOUVER, British Columbia, Nov. 23, 2023 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”) a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies today announced the financial results for its fiscal third…
CLICK HERE TO SUBMIT YOUR GINKGO LOSSES LEAD PLAINTIFF DEADLINE: January 18, 2023 CLASS PERIOD: May 11, 2023 through October 5, 2023 CONTACT AN ATTORNEY TO DISCUSS YOUR RIGHTS: James Maro, Esq. (484) 270-1453 or Toll Free (844) 887-9500 or Email at…
SAN DIEGO, Nov. 23, 2023 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and commercializing specialty products for allergy, opioid overdose, respiratory and inflammatory disease, today announced that it has received a letter from the Listing…
